1. Home
  2. AEMD vs TWAV Comparison

AEMD vs TWAV Comparison

Compare AEMD & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

BUY

Current Price

$5.86

Market Cap

4.3M

Sector

Health Care

ML Signal

BUY

Logo TaoWeave Inc. Common Stock

TWAV

TaoWeave Inc. Common Stock

SELL

Current Price

$1.49

Market Cap

5.1M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
AEMD
TWAV
Founded
1984
N/A
Country
United States
United States
Employees
N/A
130
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
5.1M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
AEMD
TWAV
Price
$5.86
$1.49
Analyst Decision
Hold
Analyst Count
2
0
Target Price
★ $13.25
N/A
AVG Volume (30 Days)
★ 2.4M
75.6K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 90.77
EPS
N/A
★ 0.43
Revenue
N/A
★ $2,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.38
Revenue Growth
N/A
★ 2.48
52 Week Low
$0.53
$0.58
52 Week High
$35.97
$2.58

Technical Indicators

Market Signals
Indicator
AEMD
TWAV
Relative Strength Index (RSI) 58.98 50.13
Support Level $3.20 $1.17
Resistance Level $6.69 $1.86
Average True Range (ATR) 0.34 0.16
MACD -0.14 -0.02
Stochastic Oscillator 0.89 21.28

Price Performance

Historical Comparison
AEMD
TWAV

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.

Share on Social Networks: